Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.

The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Abstract Text:

    francesca t aweekaFrancesca T Aweeka,susan l rosenkranzSusan L Rosenkranz,yoninah segalYoninah Segal,robert w coombsRobert W Coombs,arlene bardeguezArlene Bardeguez,lourdes thevanayagamLourdes Thevanayagam,patricia lizakPatricia Lizak,judith abergJudith Aberg,d heather wattsD Heather Watts, ,

    OBJECTIVES: Zidovudine remains part of combination antiretroviral therapy. Pharmacological studies rely on quantitation of active triphosphates in peripheral blood mononuclear cells. This study evaluated the impact of female sex and contraceptive therapy on zidovudine plasma and intracellular pharmacokinetics and the impact of contraceptive therapy on HIV viral load. METHODS: Serial plasma and intracellular zidovudine pharmacokinetics following oral and intravenous dosing were determined in 18 men and 20 women treated with zidovudine. Women could repeat pharmacokinetics assessment following 2 months oral or injectable contraceptive therapy. Zidovudine plasma and intracellular mono-, di- and triphosphate concentrations were determined by liquid chromatography tandem mass spectrometry. Plasma and cervical viral loads were determined preceding and following 2 months of contraceptive therapy in women. RESULTS: Men exhibited higher area under the concentration versus time curve for intracellular zidovudine and zidovudine-monophosphate following oral and intravenous dosing and higher zidovudine triphosphate following oral dosing. There was no difference between men and women in plasma zidovudine parameters. Furthermore, contraceptive therapy had no effect on zidovudine plasma or intracellular pharmacokinetics or on plasma or cervical HIV-1 RNA levels. CONCLUSIONS: Using an optimized pharmacokinetic design, this study indicated men exhibit significantly higher zidovudine-monophosphate and zidovudine-triphosphate exposure following zidovudine oral administration, having implications for drug toxicity and overall tolerance of zidovudine therapy. The lack of an effect of contraceptive therapy on zidovudine pharmacokinetics is surprising in light of previous pharmacokinetic studies for drugs eliminated primarily through glucuronidation. Contraceptive therapy had no effect on plasma or cervical viral load, results consistent with previous findings.

    The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Publishing Authors By Initials

    ft aweekaFT Aweeka,sl rosenkranzSL Rosenkranz,y segalY Segal,rw coombsRW Coombs,a bardeguezA Bardeguez,l thevanayagamL Thevanayagam,p lizakP Lizak,j abergJ Aberg,dh wattsDH Watts, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: AIDS (London, England)

    VOLUME: 20

    Page Numbers: 1833-41

    Journal Abbreviation:

    ISSN: 0269-9370

    DAY: 11

    MONTH: Sep

    YEAR: 2006

    The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8710219

    The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.

    AFFILIATION: Drug Research Unit, University of California, San Francisco, California 94143-0622, USA. faweeka@sfghsom.ucsf.edu

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AIDS

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News